Viewing Study NCT05662332


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2025-12-25 @ 7:10 PM
Study NCT ID: NCT05662332
Status: COMPLETED
Last Update Posted: 2025-08-06
First Post: 2022-12-15
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
Sponsor: Eli Lilly and Company
Organization: